Xie C - Search Results

1

A gB nanoparticle vaccine elicits a protective neutralizing antibody response against EBV.

Sun C, Kang YF, Fang XY, Liu YN, Bu GL, Wang AJ, Li Y, Zhu QY, Zhang H, Xie C, Kong XW, Peng YJ, Lin WJ, Zhou L, Chen XC, Lu ZZ, Xu HQ, Hong DC, Zhang X, Zhong L, Feng GK, Zeng YX, Xu M, Zhong Q, Liu Z, Zeng MS. Sun C, et al. Among authors: xie c. Cell Host Microbe. 2023 Nov 8;31(11):1882-1897.e10. doi: 10.1016/j.chom.2023.09.011. Epub 2023 Oct 16. Cell Host Microbe. 2023. PMID: 37848029 Free article.

2

Identification of an N6-methyladenosine-mediated positive feedback loop that promotes Epstein-Barr virus infection.

Dai DL, Li X, Wang L, Xie C, Jin Y, Zeng MS, Zuo Z, Xia TL. Dai DL, et al. Among authors: xie c. J Biol Chem. 2021 Jan-Jun;296:100547. doi: 10.1016/j.jbc.2021.100547. Epub 2021 Mar 16. J Biol Chem. 2021. PMID: 33741341 Free PMC article.

3

Parallel profiling of antigenicity alteration and immune escape of SARS-CoV-2 Omicron and other variants.

Sun C, Kang YF, Liu YT, Kong XW, Xu HQ, Xiong D, Xie C, Liu YH, Peng S, Feng GK, Liu Z, Zeng MS. Sun C, et al. Among authors: xie c. Signal Transduct Target Ther. 2022 Feb 8;7(1):42. doi: 10.1038/s41392-022-00910-6. Signal Transduct Target Ther. 2022. PMID: 35136040 Free PMC article.

4

Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants.

Kang YF, Sun C, Sun J, Xie C, Zhuang Z, Xu HQ, Liu Z, Liu YH, Peng S, Yuan RY, Zhao JC, Zeng MS. Kang YF, et al. Among authors: xie c. Nat Commun. 2022 May 13;13(1):2674. doi: 10.1038/s41467-022-30222-w. Nat Commun. 2022. PMID: 35562337 Free PMC article.

5

Induction of Broadly Cross-Reactive Antibody Responses to SARS-CoV-2 Variants by S1 Nanoparticle Vaccines.

Sun C, Yuan RY, Xie C, Sun JF, Fang XY, Hu YS, Yu XH, Liu Z, Zeng MS, Kang YF. Sun C, et al. Among authors: xie c. J Virol. 2022 Jul 13;96(13):e0038322. doi: 10.1128/jvi.00383-22. Epub 2022 Jun 14. J Virol. 2022. PMID: 35699445 Free PMC article.

6

Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants.

Sun C, Xie C, Bu GL, Zhong LY, Zeng MS. Sun C, et al. Among authors: xie c. Signal Transduct Target Ther. 2022 Jun 28;7(1):202. doi: 10.1038/s41392-022-01039-2. Signal Transduct Target Ther. 2022. PMID: 35764603 Free PMC article. Review.

7

How EBV Infects: The Tropism and Underlying Molecular Mechanism for Viral Infection.

Bu GL, Xie C, Kang YF, Zeng MS, Sun C. Bu GL, et al. Among authors: xie c. Viruses. 2022 Oct 27;14(11):2372. doi: 10.3390/v14112372. Viruses. 2022. PMID: 36366470 Free PMC article. Review.

8

Anti-EBV antibodies: Roles in diagnosis, pathogenesis, and antiviral therapy.

Xie C, Zhong LY, Bu GL, Zhao GX, Yuan BY, Liu YT, Sun C, Zeng MS. Xie C, et al. J Med Virol. 2023 May;95(5):e28793. doi: 10.1002/jmv.28793. J Med Virol. 2023. PMID: 37212266 Review.

9

Elucidation of the neutralizing antibody evasion of emergent SARS-CoV-2 Omicron sub-lineages using structural analysis.

Sun C, Liu YT, Kang YF, Xie C, Li SX, Lu YT, Zeng MS. Sun C, et al. Among authors: xie c. Sci China Life Sci. 2023 Dec;66(12):2935-2938. doi: 10.1007/s11427-023-2393-3. Epub 2023 Sep 1. Sci China Life Sci. 2023. PMID: 37673846 No abstract available.

10

Navigating Epstein-Barr virus autoimmunity: role of NK cells and T cells in multiple sclerosis.

Xie C, Sun C, Zeng MS. Xie C, et al. Signal Transduct Target Ther. 2024 Feb 29;9(1):48. doi: 10.1038/s41392-024-01774-8. Signal Transduct Target Ther. 2024. PMID: 38424043 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,214 results

Search Page

Filters